Aishwarya Kulkarni

Sep 23, 2024 | scalemag.online | Aishwarya Kulkarni

How Leewardists Turned Comics into City Critique In a world where architecture is communicated in a complex language, Leewardists uses the simplicity of comics to make the built environment accessible and engaging for everyone. By Aishwarya KulkarniBorn from a childhood passion for graphic storytelling, Anuj Kale and Shreya Khandekar, partners of Leewardists blend humour and insight to address architectural and urban design issues.

Jun 8, 2024 | scalemag.online | Aishwarya Kulkarni

From a Sustainable Life to a Sustainable Home: Design Jatra Founded by Shardul Patil, Vinita Kaur M. Chiragia and Pratik Dhanmer, Design Jatra is an award-winning firm that encompasses the truest essence of architectural practice that goes beyond buildings.

Apr 23, 2024 | scalemag.online | Aishwarya Kulkarni

Understorey Crafting Ethical Luxury: One Knot at a Time Rooted in the rich tradition of Indian storytelling, the vision of the Understorey is to transmute the user’s narratives into exquisite rugs – timeless treasures that echo through generations. By Aishwarya Kulkarni“Hand-knotted rugs go beyond just being useful; they’re pieces of art themselves,” says Rahul Kapoor, the Co-founder of Understorey, and this truly encapsulates the essence of what Understorey stands for.

Mar 13, 2024 | scalemag.online | Aishwarya Kulkarni

Threads of Life: Shrujan Garners Talent from Kutch Shrujan, a self-sustaining NGO from Kutch, Gujarat in India brought the rich and vibrant culture of the district to India Art Fair 2024. It showcased a vibrant collection of indigenous embroidery techniques on textile base. By Aishwarya KulkarniShrujan showcased ‘Avinya’ at the India Art Fair 2024 translating to innovation and beauty in Sanskrit, realised from a collaborative, non-hierarchical method of working.

Aug 16, 2023 | biorxiv.org | Aishwarya Kulkarni |Varshini Mohan |Tracy Tang |Murray Manning

AbstractThe Hippo tumour suppressor pathway controls transcription by regulating nuclear abundance of YAP and TAZ, which activate transcription with the TEAD1-TEAD4 DNA-binding proteins. Recently, several small-molecule inhibitors of YAP and TEADs have been reported, with some now entering clinical trials for different cancers. Here, we investigated the cellular response to TEAD palmitoylation inhibitors, using a combination of genomic and genetic strategies.